Disruptive Mood Dysregulation Disorder (DMDD): Signs, Diagnosis, and Treatment

Help Is Available Right Now

If a teen or anyone else is in immediate danger, call 911.

The 988 Suicide & Crisis Lifeline is open 24/7, whether you are in crisis or worried about someone who is.

Call or text 988, or chat at 988lifeline.org.The SAMHSA National Helpline, 1-800-662-HELP (4357), offers treatment referrals and information.

 

Are your child’s emotional reactions so severe that your household feels unpredictable and exhausting? You might see explosive outbursts that seem far bigger than whatever set them off, paired with an underlying angry or irritable mood that lingers most days, even during quiet moments between episodes.

As the National Institute of Mental Health points out, these symptoms go far beyond a typical “bad mood” or standard childhood temper tantrums. Disruptive Mood Dysregulation Disorder (DMDD) involves chronic, severe irritability and frequent, intense behavioral outbursts. At BasePoint Academy, we provide specialized DMDD treatment through structured Partial Hospitalization (PHP), Intensive Outpatient (IOP), and virtual care options across Texas to help your family find stability and lasting emotional balance.

DMDD Treatment at BasePoint Academy

Treatment for Disruptive Mood Dysregulation Disorder (DMDD) at BasePoint Academy focuses on restoring emotional regulation, reducing the intensity of behavioral outbursts, and helping Texas youth build sustainable coping skills. Because DMDD affects the entire home environment, our clinical team designs individualized treatment plans tailored to each adolescent’s psychological, academic, and family needs.

Care plans draw on individual, group, and family therapy, incorporating Cognitive Behavioral Therapy (CBT) and Dialectical Behavior Therapy (DBT) skill-building to help teens identify emotional triggers and manage distress effectively. A comprehensive psychiatric evaluation guides every treatment strategy, ensuring an accurate diagnosis and identifying any co-occurring disorders, such as ADHD and anxiety.

BasePoint Academy Accepts Health Insurance

We accept most major health insurance providers in Texas and can check your treatment coverage levels on your behalf.

7:00 am to 7:00 pm
7 Days a week

When medically indicated, medication management is integrated into the plan to stabilize mood and support overall therapeutic progress. To ensure continuity throughout recovery, BasePoint Academy professionals also coordinate closely with your teen’s school, aligning academic accommodations with therapeutic goals so they can maintain educational progress during mental health care.

Accessing specialized DMDD treatment across Texas should be clear and straightforward for families. That’s why BasePoint Academy works in-network with most major insurance providers to minimize out-of-pocket expenses. Our admissions team handles the entire verification process before enrollment, clarifies policy benefits, and helps you focus on your child’s health. For more information on benefits and DMDD treatment options, call (972) 357-1749.

Partial Hospitalization (PHP) for DMDD

BasePoint Academy’s Partial Hospitalization Program (PHP) offers a comprehensive level of support for adolescents experiencing severe emotional dysregulation or frequent behavioral crises. If your 11- to 18-year-old requires a higher level of therapeutic intervention than traditional weekly outpatient therapy can deliver, PHP provides full therapeutic days, 5 days a week.

Texas youth engage in immersive individual therapy, peer group processing, and skill-building sessions while returning home each evening. This high level of care provides rigorous psychiatric oversight and daily therapeutic support while maintaining vital connections to daily routines. By practicing newly learned emotional regulation strategies at home overnight, coping tools are refined in real time.

Intensive Outpatient (IOP) for DMDD

The Intensive Outpatient Program (IOP) provides a flexible, step-down level of care for teens who need structured therapeutic support while continuing their daily academic and personal schedules. Meeting several days per week, IOP reinforces therapeutic skills learned in CBT and DBT. The outpatient program builds distress tolerance and addresses interpersonal conflicts that trigger outbursts.

IOP takes place during designated hours a few times a week, with the option of evening scheduling. Regardless, BasePoint Academy ensures academic continuity so your teen can balance their schoolwork with comprehensive mental health care. IOP offers the ideal balance of clinical accountability and independence, integrating emotional regulation techniques directly into your teen’s daily life.

Virtual DMDD Treatment Across Texas

If you’re seeking flexible care or live too far from a BasePoint Academy treatment center to commute, BasePoint Reach offers virtual DMDD treatment statewide. Our specialized telehealth platform delivers the same evidence-based therapies, group skill sessions, and psychiatric treatment programs directly to your home anywhere in Texas.

  • Arlington, Texas: 3900 Arlington Highlands Blvd Suite 237, Arlington, TX 76018
  • Forney, Texas: 713 W Broad St Suite 200, Forney, TX 75126
  • Frisco, Texas: 8275 Judges Way #100i, Frisco, TX 75036
  • McKinney, Texas: 4733 Medical Center Dr, McKinney, TX 75069
  • North Richland Hills: 8479 Davis Blvd Suite 100, North Richland Hills, TX 76182

Contact BasePoint Academy Today

Contact us today to schedule a confidential assessment for your teen with a licensed clinician.

You can also get in touch to talk with our mental health experts about treatment needs, care options and your insurance coverage levels.

Call: (972) 357-1749Check Your Insurance

What Is Disruptive Mood Dysregulation Disorder (DMDD)?

DMDD is a pediatric mental health condition characterized by severe, chronic irritability, continuous anger, and frequent, intense temper outbursts. Added to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013 under the depressive disorders category, DMDD was established in response to growing clinical concern that children presenting with persistent irritability were frequently being misdiagnosed with bipolar disorder.

Because it’s a relatively recent diagnostic classification, overall prevalence rates remain difficult to pinpoint precisely; however, epidemiological estimates suggest a 3-month prevalence ranging from 0.8% to 3.3%, with the highest frequencies observed among preschool-aged children. Yale Medicine notes that while DMDD is diagnosed exclusively in youth aged 6 to 18, most initial diagnoses occur between ages 6 and 10. For older children or adolescents to meet diagnostic criteria, symptoms must have started before age 10.

It’s exceedingly rare for DMDD to present as an isolated diagnosis. Clinical research indicates that co-occurring disorders are present in a majority of diagnosed children, with ADHD, anxiety disorders, and major depression representing the most frequent comorbidities. These overlapping diagnostic profiles often complicate clinical presentations, making comprehensive psychiatric evaluation essential for distinguishing core mood dysregulation from co-occurring behavioral and emotional challenges.

While researchers don’t yet know the precise underlying causes of DMDD, current clinical consensus points to a complex interaction of neurobiological and environmental influences. Key predisposing factors and clinical markers include a personal history of Oppositional Defiant Disorder (ODD), ADHD, or anxiety, alongside family histories of depressive disorders or early exposure to psychological trauma.

The Frequent Overlap Between Oppositional Defiant Disorder (ODD) and DMDD

Clinical Psychology Review states that the DSM-5 indicates that adolescents who meet the criteria for both conditions receive only a DMDD diagnosis. In contrast, the ICD-11 integrates chronic irritability directly into the ODD spectrum by establishing a specific ODD subtype characterized by chronic anger and irritability.

Feature / Diagnostic Manual

Diagnostic & Statistical Manual of Mental Disorders (DSM-5)

International Classification of Diseases (ICD-11)

Diagnostic Rule for Co-occurrence

Explicitly prohibits DMDD co-occurring with ODD; DMDD takes precedence over ODD

Incorporates chronic irritability directly into the ODD diagnostic framework

Classification Approach

Classifies DMDD under depressive disorders to distinguish it from behavioral disorders

Establishes a specific ODD subtype characterized by chronic anger and irritability

Primary Clinical Focus

Separates chronic mood dysregulation from episodic or persistent defiant behavior

Views chronic irritability as a dimensional feature within the broader oppositional spectrum

Get Help at BasePoint Academy for Teen Disruptive Mood Dysregulation Disorder

Our mental health assessment with a licensed clinician will recommend the appropriate treatment plan if your teen struggles with DMDD. After reviewing your coverage details, we can estimate the cost of an outpatient therapy program. Call us today at (972) 357-1749 to schedule a complimentary same-day assessment or complete our inquiry form.

Start the Admissions Process for Teen DMDD

Signs and Symptoms of DMDD

Recognizing the signs of Disruptive Mood Dysregulation Disorder (DMDD) involves looking at both the intensity of temper outbursts and the baseline mood between them. While all children experience occasional frustration or moodiness, DMDD presents as a persistent pattern of severe emotional and behavioral dysregulation that goes far beyond typical childhood behavior.

  • Severe, Frequent Temper Outbursts: Outbursts occur, on average, 3 or more times per week and can be verbal (such as intense screaming or yelling) or behavioral (such as physical aggression or hitting).
  • Chronic Irritability Between Episodes: According to the DSM-5, a child with DMDD maintains an angry or irritable mood most of the day, nearly every day, and it’s noticeable.
  • Persistent Duration: Severe outbursts and a persistent negative mood must be present for at least 12 consecutive months, without a period of 3 or more months free of symptoms.
  • Multi-Setting Impairment: Ongoing irritability and outbursts cause significant functional impairment in at least two settings, such as at home, at school, or among peers, and are severe in at least one of those environments. 

 

The key distinction lies in the severity and proportion of the reaction. While everyday tantrums align with a child’s developmental stage and resolve quickly, the National Institute of Mental Health emphasizes that DMDD outbursts are completely out of proportion to the situation and far more severe than expected for the child’s age.

A sad teen girl sitting on a windowsill and looking outdoors

Contact BasePoint Academy Today

Contact us today to schedule a confidential assessment for your teen with a licensed clinician.

You can also get in touch to talk with our mental health experts about treatment needs, care options and your insurance coverage levels.

Call: (972) 357-1749Check Your Insurance

How DMDD Is Diagnosed

DMDD diagnosis involves a comprehensive clinical evaluation, as no medical scan, laboratory test, or single diagnostic tool can confirm the condition. Professionals gather detailed behavioral and developmental histories from parents, guardians, and educators to assess the frequency and context of outbursts across environments against the DSM-5 criteria.

Because no validated diagnostic rating scales exist specifically for DMDD, clinicians rely on structured psychiatric interviews and careful differential screening to rule out conditions such as depression, anxiety disorders, and PTSD. To prevent diagnostic inflation and ensure appropriate treatment targeting, the DSM-5 prohibits diagnosing DMDD alongside Oppositional Defiant Disorder (ODD), Intermittent Explosive Disorder (IED), or pediatric bipolar disorder.

At BasePoint Academy, the first step toward diagnostic clarity is a comprehensive evaluation by a licensed mental health clinician. We offer same-day assessments to help Texas families like yours access timely mental health support.

How DMDD Is Treated

Because DMDD is a relatively recent diagnostic classification, research surrounding targeted treatment protocols is still evolving. Few DMDD-specific clinical trials have been completed to date. Consequently, current evidence-based approaches are largely adapted from interventions proven effective in treating other conditions involving severe irritability, such as ADHD, oppositional defiant disorder, and anxiety disorders.

Psychotherapeutic interventions are generally recommended as the primary line of treatment, though healthcare providers may combine psychotherapy with pharmacotherapy depending on the severity of symptoms and safety concerns. Cognitive Behavioral Therapy (CBT) is frequently used to help youth identify the root causes of their anger and modify disruptive behavioral patterns. 

A teen girl and her parents attend a therapy session

Dialectical Behavior Therapy for Children (DBT-C) is also widely employed to teach mindfulness, emotional regulation skills, and distress tolerance. Furthermore, clinical consensus among DMDD experts highlights the value of psychoeducation and structured family therapy to strengthen systemic support and reduce environmental stressors within the home.

When medication is incorporated into a treatment plan, it’s used to manage specific symptom clusters alongside psychotherapy. Because the U.S. Food and Drug Administration (FDA) has not approved any medications specifically for DMDD, prescribing strategies focus on addressing targeted symptom groups:

  • Psychostimulants: Prescribed to help reduce impulsivity and underlying irritability, particularly when ADHD is also present
  • Antidepressants: Sometimes considered to support mood stabilization, though they require careful monitoring due to the potential risk of increased suicidal ideation in youth
  • Atypical Antipsychotics: Typically reserved for managing severe aggression or physical outbursts when other interventions have proven insufficient


Because clinical agreement on optimal prescribing patterns remains varied, medication strategies must be tailored to the individual and managed by a qualified psychiatrist.

Does DMDD Go Away?

The long-term trajectory of DMDD carries both challenges and reasons for optimism. According to the National Institute of Mental Health (NIMH) and Yale Medicine, the outward behavioral symptoms of DMDD, specifically the explosive physical and verbal temper outbursts, frequently lessen or fade as children mature into late adolescence and adulthood.

The underlying emotional dysregulation often evolves rather than disappearing entirely. It frequently shifts from overt behavioral disruptions toward internalizing symptoms such as anxiety and depression. Long-term epidemiological research underscores this developmental evolution. A landmark community study published in the American Journal of Psychiatry found that young adults who met diagnostic criteria for DMDD during childhood experienced significantly higher rates of anxiety and depressive disorders in adulthood compared to peers with no history of childhood psychiatric diagnoses.

While DMDD presents ongoing developmental considerations, early intervention plays a pivotal role in shaping long-term outcomes. As clinical experts at Yale Medicine note, comprehensive evidence-based treatment may lead to meaningful improvements in emotional control, social functioning, and overall quality of life. By equipping children with distress tolerance tools and helping families create structured home environments, therapeutic care helps reduce long-term risks and lays the foundation for lasting emotional stability.

Furthermore, because DMDD is a relatively new diagnostic classification, clinical understanding of the childhood condition continues to evolve. Ongoing research and longitudinal studies are actively refining diagnostic precision, clarifying long-term outcomes, and evaluating targeted psychotherapeutic and pharmacological interventions. As research advances, treatment strategies will continue to become more specialized, offering clearer guidance and improved long-term support for affected youth and their families.

Frequently Asked Questions About DMDD

Is DMDD a Form of Bipolar Disorder?

No, DMDD is not a form of bipolar disorder. It’s a depressive disorder characterized by continuous, everyday irritability and frequent temper outbursts. Bipolar disorder involves distinct, episodic periods of mania or hypomania. To ensure diagnostic clarity and accurate treatment, the DSM-5 explicitly prohibits diagnosing both conditions in the same child.

Is DMDD on the Autism Spectrum?

No, DMDD and Autism Spectrum Disorder (ASD) are distinct neurodevelopmental and psychiatric diagnoses. While severe irritability can occur in both conditions and they may co-exist, they have fundamentally different clinical criteria, making a comprehensive psychological evaluation essential. Notably, certain atypical antipsychotic medications FDA-approved to treat irritability associated with autism are sometimes prescribed off-label to manage severe DMDD symptoms.

Can a Teenager Be Diagnosed With DMDD?

Yes, an adolescent can receive a DMDD diagnosis up to age 18, provided their symptoms began before age 10. While most initial diagnoses are established between ages 6 and 10, older children and teens who demonstrated early-onset chronic irritability and outbursts remain eligible for diagnosis.

Is There Medication for DMDD?

Currently, the FDA hasn’t approved any medications specifically to treat DMDD. Healthcare providers may employ medications, such as stimulants, antidepressants, or atypical antipsychotics, approved for related pediatric conditions to address specific symptom clusters. For a complete breakdown of pharmacological and therapeutic approaches, contact BasePoint Academy today.

Contact BasePoint Academy Today

Does your teen have symptoms of disruptive mood dysregulation disorder?  If you are concerned about your teenager’s mental health, contact BasePoint Academy for an assessment and treatment recommendations.